Skip to content
M

Mohamed Kamal Zahra

Publications (4)

Impact of Factor VII Polymorphism on Responsiveness to Warfarin Anticoagulant Therapy

Omyma Hassan Shaaban, Hesham Ahmed El Serogy, Mohamed Kamal Zahra & Amr Mahmoud Abourahma · Journal of Advances in Medicine and Medical Research · 2023

Background: Oral anticoagulants (OAs) are drugs prescribed to reduce the risk of stroke and systemic embolism in non-valvular atrial fibrillation patients, and to treat and decrease the incidence of deep vein thrombosis and pulmonary embolism. We aimed to clarify the impact of fa...

Open access Research Article 10.9734/jammr/2023/v35i235286

Progranulin/ Tumor Necrosis Factor-\(\alpha\) Ratio in Rheumatoid Arthritis

Rabab Hamdy Mohamed, Enayat Ali Badr, Samy Abd-el-Kader Khoder & Mohamed Kamal Zahra · Journal of Advances in Medicine and Medical Research · 2022

Background: Progranulin (PGRN) has significant functions in several processes, including immune response and the development of cancer. This study aims to research the relationship between the ratio of serum progranulin/tumor necrosis factor (TNF) alpha and the rheumatoid arthrit...

Open access Research Article 10.9734/jammr/2022/v34i1931444

CD4 and CXCR5 in Patients with Diabetic Nephropathy

Sara Zaghloul Abdelhameed, Wesam Salah Mohamed, Kamal Mohamed Okasha & Mohamed Kamal Zahra · Journal of Advances in Medicine and Medical Research · 2021

Background: Diabetes is a metabolic condition characterized by hyperglycemia caused by defects in insulin secretion, insulin activity, or both. Diabetic nephropathy (DN) is one of the most common complications of diabetes mellitus especially type 2 diabetes. Blood CXCR5+CD4+ T ce...

Open access Research Article 10.9734/jammr/2021/v33i2031123

JAK2 V617F Mutation in Patients with Thrombosis

Azza Ibrahim Ismail Raslan, Heba Ahmed Mourad, Amira Youssef Ahmed, Atef Mohamed Taha & Mohamed Kamal Zahra · Journal of Advances in Medicine and Medical Research · 2023

Background: Thrombosis is a major disorder with serious complications. The JAK2V617F mutation results in constitutive phosphorylation of JAK2 and activation of the cellular proliferation cascade. The present study aimed to clarify the prevalence of JAK2V617F mutation in patients...

Open access Research Article 10.9734/jammr/2023/v35i165085